Pandemic Perspectives: A Lasting Impact On Medtech, But Not Dealmaking
Executive Summary
The COVID-19 pandemic has fundamentally changed health care and the life sciences, KPMG analyst Kristin Pothier concludes in a new report on the medtech investment outlook.
You may also be interested in...
KPMG Speaks On What 2022 Medtech Investment May Look Like
2021 was a busy year in the medtech investment space. How will 2022 compare?
Investor Eye: Octopus Ventures Tackles Tough, Taboo Problems In Health Care
In an interview with Medtech Insight, Octopus Ventures partner Pooja Sikka explained the approach Octopus takes to investments, and the key challenges the fund wants to address.
Tyto Care Raises $50M In Series D To Expand Telehealth Platform
Tyto Care will use the proceeds to expand its telehealth and remote monitoring solution to the US, Europe, and Asia, and add AI capabilities.